WHITEHAWK THERAPEUTICS, INC. (WHWK) Revenue 2018–2025
WHITEHAWK THERAPEUTICS, INC. (WHWK) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$7.1MFY2025 · since FY2018: $20.2M → $7.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.1M | -72.5% |
| FY2024 | $26.0M | +6.7% |
| FY2023 | $24.4M | +60.1% |
| FY2022 | $15.2M | +8.7% |
| FY2021 | $14.0M | +0.0% |
| FY2020 | $14.0M | — |
| FY2019 | $0 | -100.0% |
| FY2018 | $20.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More WHWK financial trends
WHWK Net incomeWHWK Net marginWHWK Gross profitWHWK Gross marginWHWK Operating incomeWHWK Operating marginWHWK Operating cash flowWHWK Free cash flowWHWK Capital expendituresWHWK Return on equityWHWK Stock buybacksWHWK Dividends paidWHWK Total assetsWHWK Total liabilitiesWHWK Shareholders’ equityWHWK overview →